Countagen is a Stockholm-based biotechnology company comited to accelerate the pace of gene editing advancements by providing high-resolution gene editing characterization.

Out technology platform, LockSeq, is a novel targeted NGS library preparation based on a unique gap-fill chemistry that minimizes target dropouts and amplification bias, enabling routine and standardized gene editing characterization at every stage of development.

The LockSeq Advantage:
- Simultaneous Indel Profiling: Profile and validate hundreds of genomic loci in a single reaction.
- High Sensitivity: Robust detection of on- and off-target edits down to 0.1% frequency.
- Broad Compatibility: Compatibility across sequencing platforms.
- Cost-Efficient Scalability: Scale panels and samples with minimal target dropout and uniform target capture.

📍 Based in the SciLifeLab / Karolinska Institutet ecosystem, Solna.

Countagen

Org chart

Teams

Offices